cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Insmed Incorporated
5 own
4 watching
Current Price
$24.16
$-0.37
(-1.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,428.44M
52-Week High
52-Week High
32.00000
52-Week Low
52-Week Low
18.31000
Average Volume
Average Volume
1.66M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization4,428.44M
icon52-Week High32.00000
icon52-Week Low18.31000
iconAverage Volume1.66M
iconDividend Yield--
iconP/E Ratio--
What does the Insmed Incorporated do?
Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company's lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey.
Read More
How much money does Insmed Incorporated make?
News & Events about Insmed Incorporated.
Zolmax
11 months ago
Insmed Incorporated (NASDAQ:INSM Get Rating) has been assigned a consensus rating of Buy from the eleven brokerages that are presently covering the stock, Marketbeat reports. Eleven investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that ...
Ticker Report
11 months ago
Insmed Incorporated (NASDAQ:INSM Get Rating) has received a consensus recommendation of Buy from the eleven research firms that are presently covering the stock, MarketBeat reports. Eleven research analysts have rated the stock with a buy rating. The average twelve-month price ...
PR Newswire
1 year ago
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., May 5, 2023 BRIDGEWATER, N.J., May 5, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical...
TipRanks Financial Blog
1 year ago
Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Insmed (INSM Research Report) today and set a price target of $28.00. The ... Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Insmed (INSM &#8211...
PR Newswire
1 year ago
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., April 6, 2023 BRIDGEWATER, N.J., April 6, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
Frequently Asked Questions
Frequently Asked Questions
What is Insmed Incorporated share price today?
plus_minus_icon
Can Indians buy Insmed Incorporated shares?
plus_minus_icon
How can I buy Insmed Incorporated shares from India?
plus_minus_icon
Can Fractional shares of Insmed Incorporated be purchased?
plus_minus_icon
What are the documents required to start investing in Insmed Incorporated stocks?
plus_minus_icon
What is today’s traded volume of Insmed Incorporated?
plus_minus_icon
What is today’s market capitalisation of Insmed Incorporated?
plus_minus_icon
What is the 52-Week High and Low Range of Insmed Incorporated?
plus_minus_icon
What percentage is Insmed Incorporated down from its 52-Week High?
plus_minus_icon
What percentage is Insmed Incorporated up from its 52-Week Low?
plus_minus_icon
Current Price
$24.16
$-0.37
(-1.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00